Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 50 of 76 entries
View as:

Analysis of the Eye in Patients With Primary Open-Angle Glaucoma and a Visual Field Defect in One Eye

Phase: N/A Priority: Normal
NCT ID: NCT02622191 Org: User:
Start: 11/30/12 End: 12/31/13 Due: 12/31/14

Novel Glaucoma Diagnostics

Phase: N/A Priority: Normal
NCT ID: NCT00286637 Org: User:
Start: 08/01/00 End: 07/31/29 Due: 07/31/30

Improving Follow-Up Adherence in a Primary Eye Care Setting

Phase: N/A Priority: Normal
NCT ID: NCT02001129 Org: User:
Start: 08/31/13 End: 08/31/14 Due: 08/31/15

Will Listening to Music Make it Easier to Take a Visual Field Test?

Phase: N/A Priority: Normal
NCT ID: NCT01027039 Org: User:
Start: 06/30/08 End: 09/30/09 Due: 09/30/10

Improving Access to Eye Care in Glaucoma Patients

Phase: N/A Priority: Normal
NCT ID: NCT02982629 Org: User:
Start: 03/31/13 End: 11/30/13 Due: 11/30/14

The Changes Within the Cells of the Drainage System of the Eye in Patients With Glaucoma

Phase: N/A Priority: Normal
NCT ID: NCT02524431 Org: User:
Start: 11/30/14 End: 01/31/16 Due: 01/31/17

Comparison Study of Glaucoma Eye Care Follow-Up Adherence in a High Risk Population

Phase: N/A Priority: Normal
NCT ID: NCT02347670 Org: User:
Start: 08/31/14 End: 12/31/15 Due: 12/31/16

visuALL Field Analyzer (vFA) Compared to Standard Humphrey Automated Perimetry

Phase: N/A Priority: Normal
NCT ID: NCT03804684 Org: User:
Start: 01/08/19 End: 10/20/20 Due: 10/20/21

Dorzolamide-timolol Drops With Injections to Treat AMD, RVO or DME.

Phase: N/A Priority: Normal
NCT ID: NCT02571972 Org: User:
Start: 02/01/15 End: 12/20/15 Due: 12/20/16

Dorzolamide-timolol in Combination With Anti-vascular Endothelial Growth Factor Injections for Wet Age-related Macular Degeneration

Phase: N/A Priority: Normal
NCT ID: NCT03034772 Org: User:
Start: 02/08/17 End: 07/05/19 Due: 07/05/20

Does Lowering Eye Pressure Affect the Results Obtained From Objective Visual Field Testing?

Phase: N/A Priority: Normal
NCT ID: NCT00799994 Org: User:
Start: 10/31/04 End: 01/31/07 Due: 01/31/08

Spaeth/Richman Contrast Sensitivity Test

Phase: N/A Priority: Normal
NCT ID: NCT01300949 Org: User:
Start: 01/31/10 End: 04/30/14 Due: 04/30/15

Eye Injections of Bevacizumab for Lowering Risk of Scar Tissue in the Retina and Repeated Retinal Detachment.

Phase: N/A Priority: Normal
NCT ID: NCT01860586 Org: User:
Start: 06/30/13 End: 11/30/14 Due: 11/30/15

Comparative Study of Sharkskin Versus Grieshaber Forceps During ILM Peeling

Phase: N/A Priority: Normal
NCT ID: NCT04459949 Org: User:
Start: 07/06/20 End: 06/01/21 Due: 06/01/22

Building a Database of Results From People Without Eye Problems

Phase: N/A Priority: Normal
NCT ID: NCT02627339 Org: User:
Start: 08/31/12 End: 08/31/15 Due: 08/31/16

Comparison of Gonioscopy With Cirrus and Visante

Phase: N/A Priority: Normal
NCT ID: NCT01895686 Org: User:
Start: 11/30/11 End: 11/30/12 Due: 11/30/13

Treatment of Port-wine Mark in Sturge-Weber Syndrome Using Topical Timolol

Phase: N/A Priority: Normal
NCT ID: NCT01533376 Org: User:
Start: 02/29/12 End: 02/28/19 Due: 02/28/20

Will the Use of Triesence During Glaucoma Surgery Provide Lower Eye Pressure and Improve the Results of the Surgery?

Phase: N/A Priority: Normal
NCT ID: NCT00853905 Org: User:
Start: 02/28/09 End: 01/31/12 Due: 01/31/13

Pain Reduction With Topical Bromfenac Versus Artificial Tear After Intravitreal Injection.

Phase: N/A Priority: Normal
NCT ID: NCT06130384 Org: User:
Start: 03/01/21 End: 11/15/23 Due: 11/15/24

Study of Patient Use and Perception of the Travatan Dosing Aid

Phase: N/A Priority: Normal
NCT ID: NCT00626067 Org: User:
Start: 09/30/06 End: 02/28/07 Due: 02/28/08

Sub-Tenon Triamcinolone in the Prevention of Radiation-Induced Macular Edema

Phase: N/A Priority: Normal
NCT ID: NCT00441662 Org: User:
Start: 11/30/04 End: 05/31/07 Due: 05/31/08

Philadelphia Telemedicine Glaucoma Detection and Follow-Up Study

Phase: N/A Priority: Normal
NCT ID: NCT02390245 Org: User:
Start: 09/30/14 End: 08/31/20 Due: 08/31/21

The Safety & Efficacy of Intravitreal Aflibercept Injection in Patients With Persistent Central Serous Chorioretinopathy

Phase: N/A Priority: Normal
NCT ID: NCT01710332 Org: User:
Start: 10/31/12 End: 06/30/13 Due: 06/30/14

Comparing the Effect of the Water Drinking Test on Intraocular Pressure

Phase: N/A Priority: Normal
NCT ID: NCT02001155 Org: User:
Start: 07/31/13 End: 07/31/14 Due: 07/31/15

Evaluating Home Testing Devices for the Management of Glaucoma

Phase: N/A Priority: Normal
NCT ID: NCT05325996 Org: User:
Start: 04/15/22 End: 12/31/26 Due: 12/31/27